Cargando…

Modifying the multi-arm multi-stage (MAMS) design for use in a phase II tuberculosis trial in sub-Saharan Africa with a time-to-event primary outcome

Detalles Bibliográficos
Autores principales:	Phillips, Patrick, Hoelscher, Michael, Bratton, Daniel, Rehal, Sunita, Heinrich, Norbert, van Balen, Georgette Plemper, Nunn, Andrew, Aarnoutse, Rob, Henne, Sonja, Gillespie, Stephen, Boeree, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980407/ http://dx.doi.org/10.1186/1745-6215-14-S1-P26

Ejemplares similares

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
por: Boeree, Martin J, et al.
Publicado: (2017)

A multi-arm multi-stage design for binary outcomes and application to tuberculosis
por: Bratton, Daniel, et al.
Publicado: (2013)

A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis
por: Bratton, Daniel J, et al.
Publicado: (2013)

A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)
por: Phillips, Patrick P. J., et al.
Publicado: (2016)

Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trials
por: Noor, Nurulamin M, et al.
Publicado: (2022)

Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes
por: Bratton, Daniel J., et al.
Publicado: (2016)

Increased bactericidal activity but dose-limiting intolerability at 50 mg·kg(−1) rifampicin
por: te Brake, Lindsey H.M., et al.
Publicado: (2021)

The design of a multi-arm multi-stage (MAMS) phase III randomised controlled trial comparing alternative regimens for escalating (COMPARE) treatment of intermediate and high-risk oropharyngeal cancer with reflections on the complications of introducing a new experimental ARM
por: Gaunt, Piers, et al.
Publicado: (2015)

Ta yol Mam : txolil ta tsi'b'enj te ta yol mam = Norma de escritura de la lengua mam.
Publicado: (2011)

Wolfram syndrome: MAMs’ connection?
por: Delprat, Benjamin, et al.
Publicado: (2018)

Modular Robots + Synchronous Robots + Multi-arm Robots
por: Buckingham, Rob
Publicado: (2003)

Contribution of genetic variation within SuprMam1 and SuprMam2 to breast cancer susceptibility
por: Ratnadiwakara, M, et al.
Publicado: (2012)

The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis
por: Svensson, Elin M, et al.
Publicado: (2018)

Mitochondria-associated membranes (MAMs) and pathologies
por: Pinton, Paolo
Publicado: (2018)

Mitochondria-associated membranes (MAMs) and inflammation
por: Missiroli, Sonia, et al.
Publicado: (2018)

MamX encoded by the mamXY operon is involved in control of magnetosome maturation in Magnetospirillum gryphiswaldense MSR-1
por: Yang, Jing, et al.
Publicado: (2013)

A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses
por: Svensson, Robin J., et al.
Publicado: (2017)

Some recommendations for multi-arm multi-stage trials
por: Wason, James, et al.
Publicado: (2012)

Introduction to multi-armed bandits
por: Slivkins, Aleksandrs
Publicado: (2019)

Genomic Origin and Diversification of the Glucosinolate MAM Locus
por: Abrahams, R. Shawn, et al.
Publicado: (2020)

The MAMs Structure and Its Role in Cell Death
por: Wang, Nan, et al.
Publicado: (2021)

Optimal design for multi-arm multi-stage clinical trials
por: Wason, James MS, et al.
Publicado: (2011)

Treatment selection in multi-arm, multi-stage clinical trials
por: Jaki, Thomas, et al.
Publicado: (2013)

Tuberculosis Molecular Bacterial Load Assay Reveals Early Delayed Bacterial Killing in Patients With Relapse
por: Ntinginya, Nyanda Elias, et al.
Publicado: (2022)

Multiplicity adjustments in parallel-group multi-arm trials sharing a control group: Clear guidance is needed
por: Molloy, Síle F., et al.
Publicado: (2022)

Multi-arm covariate-adaptive randomization
por: Hu, Feifang, et al.
Publicado: (2022)

Calcium signaling around Mitochondria Associated Membranes (MAMs)
por: Patergnani, Simone, et al.
Publicado: (2011)

Las partes del cuerpo humano en mam
por: Quintana Hernández, Francisca
Publicado: (2011)

Of yeast, mice and men: MAMs come in two flavors
por: Herrera-Cruz, Maria Sol, et al.
Publicado: (2017)

Glucosinolate biosynthesis: role of MAM synthase and its perspectives
por: Das, Bidyadhar
Publicado: (2021)

A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxacin in adult subjects with newly diagnosed, uncomplicated, smear-positive, drug-sensitive pulmonary tuberculosis
por: Dierig, A, et al.
Publicado: (2023)

An order restricted multi‐arm multi‐stage clinical trial design
por: Serra, Alessandra, et al.
Publicado: (2022)

Genome-wide kinase-MAM interactome screening reveals the role of CK2A1 in MAM Ca(2+) dynamics linked to DEE66
por: Thi My Nhung, Truong, et al.
Publicado: (2023)

Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials
por: Kahan, Brennan C, et al.
Publicado: (2014)

Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development
por: Ayoun Alsoud, Rami, et al.
Publicado: (2023)

An optimised multi-arm multi-stage clinical trial design for unknown variance
por: Grayling, Michael J., et al.
Publicado: (2018)

A multi-stage drop-the-losers design for multi-arm clinical trials
por: Wason, James, et al.
Publicado: (2016)

Rifampicin Can Be Given as Flat-Dosing Instead of Weight-Band Dosing
por: Susanto, Budi O, et al.
Publicado: (2019)

MamPol: a database of nucleotide polymorphism in the Mammalia class
por: Egea, Raquel, et al.
Publicado: (2007)

Mitochondria-associated ER membranes (MAMs) and lysosomal storage diseases
por: Annunziata, Ida, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vo76gq7mjubrrtt5nm5eoqh2ht